PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2006 | 5 |
| 2007 | 12 |
| 2008 | 11 |
| 2009 | 19 |
| 2010 | 13 |
| 2011 | 34 |
| 2012 | 41 |
| 2013 | 36 |
| 2014 | 47 |
| 2015 | 52 |
| 2016 | 54 |
| 2017 | 27 |
| 2018 | 58 |
| 2019 | 40 |
| 2020 | 101 |
| 2021 | 71 |
| 2022 | 49 |
| 2023 | 32 |
| 2024 | 33 |
| 2025 | 17 |
| 2026 | 4 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Eur Urol"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis.
- Kishan AU, Sun Y, Parker CC, Sargos P, Sydes M, Chabaud S, Brihoum M, Supiot S, Latorzeff I, Guerif S, Kalbasi TR, Steinberg ML, Valle LF, Taparra K, Farrell MJ, Shoag JE, Garcia JA, Brown JR, Rettig MB, Singer AE, Baclig N, Reiter RE, Eggener S, Brisbane W, Roy S, Jia AY, Ma TM, Nickols NG, Efstathiou JA, Dignam JJ, Seiferheld WF, Pollack A, Sandler HM, Nguyen PL, Pommier P, Spratt DE.
- Eur Urol. Author manuscript. 2026 Jul 28:S0302-2838(26)02270-0. doi: 10.1016/j.eururo.2026.07.013. Online ahead of print.
- PMCID: PMC13602305
Kishan AU, et al.Eur Urol. Author manuscript. 2026.PMCID: PMC13602305 -
Re: Bladder-preserving Trimodality Treatment for High-grade T1 Bladder Cancer: Results from Phase II Protocol NRG Oncology/RTOG 0926.
- Fu MZ, Ghodoussipour S, Packiam VT.
- Eur Urol. Author manuscript. 2025 Jun 11;88(5):530-531. doi: 10.1016/j.eururo.2025.05.027.
- PMCID: PMC13501417
Fu MZ, et al.Eur Urol. Author manuscript. 2025.PMCID: PMC13501417 -
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell Carcinoma.
- Dawidek MT, Calderon LP, Shah PK, Mittal R, Ucpinar BA, Bakouny Z, Meli K, Saad E, Saliby RM, Woo HJ, Khandwala YS, Eid M, Labaki C, Machaalani M, Coleman J, Russo P, Kotecha RR, Carlo MI, Akin O, Braun DA, Choueiri TK, Reznik E, Chen YB, Motzer RJ, Voss MH, Hakimi AA.
- Eur Urol. Author manuscript. 2025 Nov 4:S0302-2838(25)04721-9. doi: 10.1016/j.eururo.2025.09.4162. Online ahead of print.
- PMCID: PMC13484703
Dawidek MT, et al.Eur Urol. Author manuscript. 2025.PMCID: PMC13484703 -
Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the Bladder.
- Myers AA, Talwar R, Duan Z, Hensley P, Lotan Y, Williams SB, Luckenbaugh AN, Li R, Kassouf W, Necchi A, Packiam VT, Shore N, Steinberg GD, Witjes JA, Schmidt B, Porten S, Hahn NM, Bree KK, Toumazis I, Zhao H, Kamat AM.
- Eur Urol. Author manuscript. 2025 Oct 4;89(2):151-162. doi: 10.1016/j.eururo.2025.09.4137.
- PMCID: PMC13454959
Myers AA, et al.Eur Urol. Author manuscript. 2025.PMCID: PMC13454959 -
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis.
- Riaz IB, Ahmed Naqvi SA, Faisal KS, He H, Rubab Khakwani KZ, Childs DS, Orme JJ, Ravi P, Singh P, Hussain SA, Chi K, Agarwal N, Merseburger AS, Davis ID, Armstrong A, Hussain MH, Smith M, Attard G, Tombal B, Fizazi K, James N, Omlin A, Gillessen S, Murad MH, Van Allen EM, Sweeney CJ, Bryce AH.
- Eur Urol. Author manuscript. 2025 Nov 4;89(1):31-44. doi: 10.1016/j.eururo.2025.09.007.
- PMCID: PMC13404207
Riaz IB, et al.Eur Urol. Author manuscript. 2025.PMCID: PMC13404207 -
Heterogeneity of the Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: A Living Interactive Systematic Review and Meta-analysis.
- Naqvi SAA, Riaz IB, Bibi A, Khan MA, Imran M, Khakwani KZR, Raina A, Anjum MU, Cobran EK, Warner JL, Hussain SA, Singh P, Childs DS, Baca SC, Orme JJ, Mateo J, Agarwal N, Gillessen S, Murad MH, Sartor O, Bryce AH.
- Eur Urol. Author manuscript. 2025 Jan 23;87(6):626-640. doi: 10.1016/j.eururo.2024.12.007.
- PMCID: PMC13404184
Naqvi SAA, et al.Eur Urol. Author manuscript. 2025.PMCID: PMC13404184 -
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.
- Bancroft EK, Page EC, McHugh J, Thomas S, Taylor N, Pope J, Evans DG, Rothwell J, Grindedal EM, Maehle L, James P, McKinley J, Mascarenhas L, Side L, Thomas T, van Leerdam ME, van Asperen CJ, Kiemeney LALM, Ringelberg J, Vlaming M, Rønlund K, Osther PJS, Helfand BT, Hutten CG, Oldenburg RA, Cybulski C, Wokolorczyk D, Ong KR, Huber C, Salinas M, Feliubadaló L, Oosterwijk JC, van Zelst-Stams WAG, Cook J, Rosario DJ, Maxwell K, Powers J, Buys S, Lyman J, Ausems MGEM, Schmutzler RK, Rhiem K, Izatt L, Tripathi V, Teixeira MR, Cardoso M, Foulkes WD, Aprikian A, Davidson R, Longmuir M, Ruijs MWG, Blom EW, van Engelen K, Williams R, Andrews L, Murphy DG, Saya S, Halliday D, Walker L, Liljegren A, Carlsson S, Azzabi A, Jobson I, Snape K, Gowie M, Harris M, Tischkowitz M, Taylor A, Kirk J, Susman R, Chen-Shtoyerman R, Spigelman A, Pachter N, Ahmed M, Cajal TRY, Krajc M, Cleaver R, Cruellas M, Perez-Ballestero E, Brady AF, Gallagher D, Donaldson A, Barwell J, Nicolai N, Friedman E, Hall MJ, Greenhalgh L, Murthy V, Copakova L, McGrath JS, Cooke P, Arun B, Myhill K, Hogben M, Hussain S, Aaronson NK, Ardern-Jones A, Bangma CH, Castro E, Dearnaley D, Eccles DM, Tricker K, Falconer A, Gronberg H,…
- Eur Urol. Author manuscript. 2026 Feb 18;89(5):457-468. doi: 10.1016/j.eururo.2026.01.031.
- PMCID: PMC13401181
Bancroft EK, et al.Eur Urol. Author manuscript. 2026.PMCID: PMC13401181 -
Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications.
- Aydogdu C, Bukavina L, Cheng L, Al-Ahmadie HA, Alhalabi O, Brown JR, Lopez-Beltran A, Grivas P, Hwang C, Grass GD, Kamat AM, Chatzkel J, Mian O, Necchi A, Ross J, Apolo AB, Spiess PE, Li R.
- Eur Urol. Author manuscript. 2026 Jun 27;90(4):377-388. doi: 10.1016/j.eururo.2026.05.030.
- PMCID: PMC13336308
Aydogdu C, et al.Eur Urol. Author manuscript. 2026.PMCID: PMC13336308 -
Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in Preclinical Models of Bladder Cancer.
- Zhou Y, D'Andrea VD, Shanmugam SP, Stelter I, Stormoen DR, Chroneos R, Hanlon T, Epstein I, Bekele RT, Anderson WJ, Carvalho FFL, Bellmunt J, Mouw KW.
- Eur Urol. Author manuscript. 2024 Mar 23;86(1):69-71. doi: 10.1016/j.eururo.2024.03.013.
- PMCID: PMC13333192
Zhou Y, et al.Eur Urol. Author manuscript. 2024.PMCID: PMC13333192 -
Longitudinal Evaluation of Clear-cell Renal Cell Carcinoma in von Hippel-Lindau Disease.
- Linehan WM, Pinto CA, Liu Y, Choo K, Gautam R, Fox C, Roy A, Li M, Bosan R, Nielsen D, Ryan B, Blake Z, Reynolds K, Rompre-Brodeur A, Pinto PA, Vocke C, Gurram S, Ball MW, Perini R, Srinivasan R.
- Eur Urol. Author manuscript. 2025 Apr 23;88(1):56-63. doi: 10.1016/j.eururo.2025.03.002.
- PMCID: PMC12167132
Linehan WM, et al.Eur Urol. Author manuscript. 2025.PMCID: PMC12167132